ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
ARF6 和 AMAP1 是 KRAS 和 TP53 突变的主要靶点，这些突变会促进胰腺癌的侵袭、PD-L1 动态变化和免疫逃逸。
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.1901765116
Hashimoto, Shigeru; Furukawa, Shotaro; Hashimoto, Ari; Tsutaho, Akio; Fukao, Akira; Sakamura, Yurika; Parajuli, Gyanu; Onodera, Yasuhito; Otsuka, Yutaro; Handa, Haruka; Oikawa, Tsukasa; Hata, Soichiro; Nishikawa, Yoshihiro; Mizukami, Yusuke; Kodama, Yuzo; Murakami, Masaaki; Fujiwara, Toshinobu; Hirano, Satoshi; Sabe, Hisataka
肿瘤
肿瘤免疫
ARF
PD-L1
P53
胰腺癌
RAS
免疫/内分泌
